Injeq

Injeq is a medical technology company dedicated to developing intelligent solutions for patient injections, with a strong focus on lumbar puncture procedures. The company aims to enhance patient safety and treatment effectiveness through innovative technology. Injeq's flagship product is the IQ-Tip® smart needle, which features continuous bioimpedance spectroscopy measurement at the needle tip. This technology allows for real-time tissue identification, significantly reducing the risk of complications during lumbar punctures. The IQ-Tip® is designed for a wide range of patients, from neonates to the elderly, including sensitive cases like spinal cavity punctures in children with leukemia. The IQ-Tip® smart needle received CE certification in December 2021, enabling Injeq to market and sell in several European countries. The company is actively expanding its distribution channels and negotiating entry into additional markets, including Spain, the Netherlands, the United Kingdom, and Poland, with plans for further growth in the United States and selected Asian countries.

• Employees 18
• Founded 2010
• Total Funding $2382880